Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2012
04/17/2012US8158360 Effects of inhibitors of FGFR3 on gene transcription
04/17/2012US8158359 Methods of amplifying and sequencing nucleic acids
04/17/2012US8158358 Method for gender identification of eagles with probe-based real-time PCR and the sequences used for gender identification of eagles
04/17/2012US8158357 Compositions and method for storage of nucleic acid from bodily fluids
04/17/2012US8158356 Screening for the genetic defect causing tibial hemimelia in bovines
04/17/2012US8158355 Method to generate or determine nucleic acid tags corresponding to the terminal ends of DNA molecules using sequences analysis of gene expression (terminal SAGE)
04/17/2012US8158354 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
04/17/2012US8158353 Species-specific and quantitative detection of CNS tissue in meat and meat products
04/17/2012US8158352 Screening of a novel hepatic syndrome and its uses
04/17/2012US8158351 Method for determining inflammatory disease
04/17/2012US8158350 Probe, probe set, probe-immobilized carrier, and genetic testing method
04/17/2012US8158349 Method and device for purifying nucleic acids
04/17/2012US8158348 Apparatus and method for preparative scale purification of nucleic acids
04/17/2012US8158347 Using expression of tumor suppression gene as diagnostic tool in evaluating effectiveness and efficacy of therapeutic modalities
04/17/2012US8158346 Labelled nucleotides
04/17/2012US8158345 Labeled oligonucleotide
04/17/2012US8158344 Methods and compositions for correlating genetic markers with multiple sclerosis
04/17/2012US8158341 Efficient algorithm for PCR testing of blood samples
04/17/2012US8158340 Methods for detecting conformational changes in bioentities
04/17/2012US8158131 Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein
04/17/2012US8158123 Suppressing bone resorption; inhibiting expression of osteoclast associated gene selected from OC 1-285, sequences 4, 34, 38 and/or 43
04/17/2012CA2695562C Lipid acyltransferase
04/17/2012CA2498636C Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
04/17/2012CA2493323C Dual reporter gene assay
04/17/2012CA2481521C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/17/2012CA2465646C Assay based on doped nanoparticles
04/17/2012CA2445700C Protein involved in restoration of cytoplasmic male sterility to fertility and gene encoding the protein and gene
04/17/2012CA2428713C Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways
04/17/2012CA2410526C Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
04/17/2012CA2377607C Neurotrophic factor receptor
04/17/2012CA2373290C Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
04/17/2012CA2157470C Mannose or xylose based positive selection
04/12/2012WO2012048340A2 High-throughput immune sequencing
04/12/2012WO2012048339A2 Selective detection of neisseria meningitidis
04/12/2012WO2012048303A2 METHOD FOR TREATING CANCER HARBORING A p53 MUTATION
04/12/2012WO2012048292A2 Igf-1 dependent modulation of vsels
04/12/2012WO2012048265A2 Methods of treating inflammation
04/12/2012WO2012048249A1 Site-specific incorporation of phosphoserine into proteins in escherichia coli
04/12/2012WO2012048236A1 Micrornas (mirna) as biomakers for the identification of familial and non-familial colorectal cancer
04/12/2012WO2012048207A2 Compositions and methods for nucleic acid based diagnostic assays
04/12/2012WO2012048136A1 Endpoint taqman methods for determining zygosity of cotton comprising cry1ac event 3006-210-23
04/12/2012WO2012048124A1 Endpoint taqman methods for determining zygosity of cotton comprising cry1f event 281-24-236
04/12/2012WO2012048113A2 Biomarkers of cancer
04/12/2012WO2012048106A2 Biomarkers useful to predict mek inhibitor drug efficacy
04/12/2012WO2012048096A2 Improved sample test cards
04/12/2012WO2012048063A2 Cyanine compounds, conjugates and method of use
04/12/2012WO2012047968A2 Mutant smoothened and methods of using the same
04/12/2012WO2012047899A2 Novel dna hypermethylation diagnostic biomarkers for colorectal cancer
04/12/2012WO2012047897A2 Processes and compositions for detecting human papilloma virus types
04/12/2012WO2012047889A2 Systems and methods for automated reusable parallel biological reactions
04/12/2012WO2012047865A2 Electrically conductive polymer nanowires with incorporated viruses
04/12/2012WO2012047852A2 Compositions and methods for modulating immunodeficiency virus transcription
04/12/2012WO2012047726A1 Methods for chromatin immuno-precipitations
04/12/2012WO2012047637A2 Assays and methods for determining risk of a macrophage-mediated disease development in a subject infected with hiv
04/12/2012WO2012047631A2 Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease
04/12/2012WO2012047595A2 Maize cytoplasmic male sterility (cms) c-type restorer rf4 gene, molecular markers and their use
04/12/2012WO2012047589A2 Assay methods using nicking endonucleases
04/12/2012WO2012047297A2 Highly multiplexed real-time pcr using encoded microbeads
04/12/2012WO2012047234A1 Compositions and methods for diagnosing autism
04/12/2012WO2012047189A2 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers and the antibiotic resistance gene mec a
04/12/2012WO2012047109A2 Mirna and mirna inhibitors that modulate adenovirus replication and/or adenovirus induced cell death
04/12/2012WO2012047015A2 Multiplex microfluidic device for selecting nucleic acid aptamers, and high throughput selection method for nucleic acid aptamers using same
04/12/2012WO2012046981A2 Real time pcr detection of single nucleotide polymorphisms
04/12/2012WO2012046874A1 Method for evaluating degree of cancerization
04/12/2012WO2012046873A1 Method for evaluating degree of cancerization
04/12/2012WO2012046872A1 Method for evaluating degree of cancerization
04/12/2012WO2012046871A1 Method for evaluating degree of cancerization
04/12/2012WO2012046859A1 Identifying information carrier for identifying subject to be identified and utilization of same
04/12/2012WO2012046797A1 Cancer stem cell mass and process for production thereof
04/12/2012WO2012046730A1 Method for activating helper t cell
04/12/2012WO2012046219A2 Compositions, methods and kits to detect adenovirus nucleic acids
04/12/2012WO2012046140A1 Enzyme mixture
04/12/2012WO2012046064A2 Cell differentiation
04/12/2012WO2012046063A2 Method of detecting risk of cancer
04/12/2012WO2012046006A2 Cancer targets
04/12/2012WO2012045905A2 Method for the diagnosis, prognosis and treatment of breast cancer metastasis
04/12/2012WO2012045889A1 Ionic signal enhancement
04/12/2012WO2012045888A1 Method for determining cancer patient survival based on analyzing tumor-infiltrating overall t-lymphocytes
04/12/2012WO2012045820A1 System and method for detection of hiv-1 clades and recombinants of the reverse transcriptase and protease regions
04/12/2012WO2012045670A1 Method for cell lysis in a pcr reaction buffer
04/12/2012WO2012045669A1 Method for cell lysis and pcr within the same reaction vessel
04/12/2012WO2012045668A1 Method for cell lysis in a rt-pcr reaction buffer
04/12/2012WO2012045568A1 Method for determining a biological pathway activity
04/12/2012WO2012045150A1 Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
04/12/2012WO2012024640A3 Mst1 as a prognostic biomarker and therapeutic target in human cancer
04/12/2012WO2012019083A3 Biosensor membrane composition, biosensor, and methods for making same
04/12/2012WO2012012135A3 Analyte sensor
04/12/2012WO2012011144A3 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
04/12/2012WO2012006534A3 Methods, compositions and kits for diagnosing and treating alzheimer's disease using mitochondrial co3 gene mutations
04/12/2012WO2012006476A3 Methods and compositions for quantifying exosomes
04/12/2012WO2012003493A3 Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use
04/12/2012WO2012002775A3 Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma
04/12/2012WO2011163526A3 Signal activated molecular delivery
04/12/2012WO2011163214A3 Microrna profiles for evaluating multiple sclerosis
04/12/2012WO2011162805A3 Prion inactivation using ozone
04/12/2012WO2011159924A3 Compositions and methods for identifying and modifying carbonaceous compositions
04/12/2012WO2011159721A3 System and method for magnetically concentrating and detecting biomarkers
04/12/2012WO2011156434A3 Nucleic acid detection and quantification by post-hybridization labeling and universal encoding
04/12/2012WO2011156366A3 Fluorogenic sensors for phospholipase c isozymes
04/12/2012WO2011156249A3 Yeast concentration and viability measurement
1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 3003